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Background: Gametocytes are the transmission stages of Plasmodium parasites, the causative agents of malaria.
As their density in the human host is typically low, they are often undetected by conventional light microscopy.
Furthermore, application of RNA-based molecular detection methods for gametocyte detection remains challenging
in remote field settings. In the present study, a detailed comparison of three methods, namely light microscopy,
magnetic fractionation and reverse transcriptase polymerase chain reaction for detection of Plasmodium falciparum
and Plasmodium vivax gametocytes was conducted.
Methods: Peripheral blood samples from 70 children aged 0.5 to five years with uncomplicated malaria who were
treated with either artemether-lumefantrine or artemisinin-naphthoquine were collected from two health facilities
on the north coast of Papua New Guinea. The samples were taken prior to treatment (day 0) and at pre-specified
intervals during follow-up. Gametocytes were measured in each sample by three methods: i) light microscopy
(LM), ii) quantitative magnetic fractionation (MF) and, iii) reverse transcriptase PCR (RTPCR). Data were analysed using
censored linear regression and Bland and Altman techniques.
Results: MF and RTPCR were similarly sensitive and specific, and both were superior to LM. Overall, there were
approximately 20% gametocyte-positive samples by LM, whereas gametocyte positivity by MF and RTPCR were
both more than two-fold this level. In the subset of samples collected prior to treatment, 29% of children were
positive by LM, and 85% were gametocyte positive by MF and RTPCR, respectively.
Conclusions: The present study represents the first direct comparison of standard LM, MF and RTPCR for
gametocyte detection in field isolates. It provides strong evidence that MF is superior to LM and can be used to
detect gametocytaemic patients under field conditions with similar sensitivity and specificity as RTPCR.
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The development of Plasmodium parasites within infected
erythrocytes can follow one of two pathways: i) asexual
reproduction for propagation within the human host or, ii)
development of sexual reproductive blood stages (gameto-
cytes) which can infect the mosquito vector when taken
up with a blood meal. While asexual reproduction causes
the clinical symptoms associated with malaria, sexual
reproduction is responsible for inter-host spread of the
parasite [1]. Gametocytes have many characteristics that
differentiate them from asexual forms including, in the
case of Plasmodium falciparum, a much longer life span
and relative metabolic inactivity during their mature
phase, which means that they are relatively resistant to
anti-malarial drugs [2-4]. Artemisinin combination ther-
apy (ACT) is, however, more effective against P. falcip-
arum gametocytes than conventional agents, such as
chloroquine or amodiaquine [5-8]. This increased effect-
iveness largely stems from the ability of ACT to destroy a
wider range of early stage gametocytes, presumably at
their sequestration sites [5,9].
Monitoring gametocyte density in clinical isolates is
necessary to assess the transmission-reducing effects of
anti-malarial drugs or in investigations aiming to quan-
tify the transmission potential of humans living in en-
demic areas [2,10]. On-site detection of gametocytes at
health facilities in malaria-endemic developing countries
would also be beneficial when primaquine is being used
to reduce P. falciparum gametocyte prevalence and thus
transmission potential. Primaquine has potential toxicity,
mainly haemolysis in G6PD-deficient individuals, and its
use should ideally be limited to confirmed P. falciparum
gametocyte carriers [2].
There is, therefore, a compelling argument for clinical
and epidemiological studies to include sensitive and reli-
able methods for the detection of gametocytes. Gameto-
cyte density in infected individuals is often too low to be
detected by standard light microscopy (LM) [11] and a
variety of molecular methods have been developed for
gametocyte detection. These include reverse transcriptase
polymerase chain reaction (RTPCR), quantitative nucleic
acid sequence based analysis (QTNASBA) and reverse
transcriptase loop mediated amplification (RTLAMP)
[4,12-16]. These methods usually target transcripts of the
P. falciparum Pfs25 gene or its homologue in Plasmodium
vivax (Pvs25). However, molecular methods for gameto-
cyte detection are not easily transferable to remote field la-
boratories or health facilities, are prone to contamination,
use expensive equipment and reagents, and require highly
trained personnel.
The aim of the present study was to assess the perform-
ance of a previously developed method for enhanced detec-
tion of gametocytes using quantitative high field gradient
magnetic fractionation (MF) under field conditions incomparison to LM and RTPCR using samples collected
during an anti-malarial clinical trial [17-19].
Methods
Background methodological considerations
It should be noted that the three methods employed in
the present study quantify gametocytes in different ways:
i) LM quantifies the number of gametocytes per white
blood cell (WBCs) (in the present study in 500
WBC) and extrapolates this value to calculate a
gametocyte density per μL based on the assumption
that 1 μL of blood contains 8,000 WBCs. The
inherent threshold of detection of LM is therefore
16 gametocytes per μL of blood [18,20];
ii) RTPCR uses Pfs25 or Pvs25 copy number as a
measure for gametocyte abundance. As the number
of these transcripts gradually increases while
gametocytes maturate, this estimate may be different
from LM-derived gametocyte counts, based on the
stage distribution gametocytes in a blood sample.
Although previous studies have derived calibration
curves that related Pfs25 abundance with mature
stage V gametocyte density, it can be expected that
field-based estimates vary considerably since blood
samples may contain a wider range of gametocyte
stages [21]. Assuming ideal performance, the
detection threshold of RTPCR is only limited by the
amount of blood subjected to amplification. In the
present study, RNA was extracted from the equivalent
of 50 μL of blood and eluted in 30 μL of RNAse free
water. Four μL of this elution were then subjected to
the amplification reaction. Therefore an equivalent
volume of 6.7 μL of blood was tested by RTPCR,
giving a theoretical detection limit of 0.13 gametocytes
per μL of blood;
iii)MF uses an internal standard (magnetic
microparticles), which is added to the sample at a
known concentration per μL of blood so that the
number of gametocytes counted per microparticle
may be extrapolated to a gametocyte density per μL of
blood. In the present study this known microparticle
concentration was 100 μL and the maximum number
of particles counted was 2,000 so that the expected
detection threshold of MF was 0.05 gametocytes
per μL of blood.
The conversion from one of these measures to another
is not always straightforward, particularly in field sam-
ples containing different stages of gametocytes that may
exhibit different levels of transcript expression and/or
different magnetic susceptibilities. Furthermore, micro-
scopic parasite and gametocyte counts as well as PCR
methods are associated with considerable error [22,23].
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tween gametocyte quantification techniques are also likely
to be associated with significant degrees of uncertainty.
Sample collection and study site
This study received ethical approval as part of a larger
clinical trial (Australian New Zealand Clinical Trials
Registry ACTRN12610000913077) assessing the effect of
recommended and novel artemisinin combination therapy
in children with uncomplicated malaria from Madang
Province in Papua New Guinea (PNG) (Medical Research
Advisory Committee, Health Department of Papua New
Guinea, approval 10.39). All research conducted on
humans complied with the Helsinki declariation. Blood
samples were collected at Mugil (n = 62) and Alexishafen
(n = 8) Health Centres on the north coast of PNG near the
town of Madang. Participants were enrolled after informed
consent had been obtained. Children with clinical or la-
boratory evidence of severe malaria according to WHO
severity criteria [24] or with co-morbidities were excluded.
Participating children were aged between 0.5 and five
years and presented either with uncomplicated P. falcip-
arum (minimum parasite density 1,000 μL−1) or P. vivax
(minimum parasite density 250 μL−1) malaria. A total of
70 children were enrolled into this study (56 with P. fal-
ciparum, 14 with P. vivax). After recruitment, all par-
ticipants were randomly assigned to receive treatment
with either artemether-lumefantrine (1.7:10 mg/kg twice
daily for three days) or artemisinin-naphthoquine (20:8 mg/
kg daily for three days). For LM and MF, blood samples
(200 μL) were collected on the day of enrolment (day 0)
and on days 1, 2, 3, 7, 14, 28, and 42. For RTPCR additional
blood samples (200 μL) were collected on days 0, 3, 7, and
28. After collection, these samples were directly trans-
ferred into a 1.5 mL tube containing the RNA preserva-
tion reagent RNAlater® (Life Technologies, Mulgrave, VIC,
Australia).
Gametocyte detection techniques
i) LM: Giemsa-stained thick blood smears were examined
and parasite density quantified independently by two
skilled microscopists with parasites counted against 500
white cells. Discrepancies were adjudicated by a senior
microscopist.
ii) MF: Diluted whole blood was subjected to high field
gradient MF as described elsewhere but a 200 μL
volume was used instead of 400 μL as in previous
studies. [17,18]. Briefly, the 200 μL blood samples
were suspended in 2 mL of MF buffer (PBS
pH = 7.4, 0.5% bovine serum albumin, 2 mM EDTA).
Magnetic particles (Spherotech, Lake Forest, IL,
USA) were added to achieve a total known particle
concentration of 100 particles per μL of blood. Thesamples were then magnetically fractionated as
previously described using MACS equipment
(Miltenyi Biotec, Bergisch Gladbach, Germany) [17]
After passage of each sample through the columns,
the columns were washed twice with 1 mL of MF
buffer. Samples were then eluted in 1 mL of MF
buffer and spun briefly to pellet the eluted material
(cells/particles). Slides were prepared using the
entire pellet. Slides prepared after MF were
examined by screening the entire slide for
gametocytes. If a gametocyte was observed,
gametocytaemia was quantitatively assessed
following the methodology described in [17] with
slight modifications, and by counting a maximum
number of 2,000 magnetic particles and the
corresponding number of gametocytes in the
associated fields. It should be noted that it takes only
approximately 5 min to scan every field on an MF
slide for gametocytes using 1,000× magnification, as
the preparations contained very few cells.
iii)RTPCR: Samples collected in the RNA preservation
reagent were transferred to a −80°C freezer as soon
as possible (usually on the same day) after collection.
RNA was extracted from the preserved samples
using the Qiagen RNeasy 96 Plus kit (Qiagen,
Doncaster, VIC, Australia) following manufacturer’s
instructions with slight modifications. The sample
volume subjected to extraction was equivalent to
50 μL of blood. Extracted RNA was eluted into
30 μL of RNAse free water. Four μL from the
elution were subjected to the RTPCR reaction
(equivalent of 6.7 μL of the original blood sample).
Details of the RTPCR assay, including mix
preparation, primer and probe sequences have been
published elsewhere [21]. Each detection experiment
included a duplicate dilution series of plasmids
containing the Pfs25 or Pvs25 target product (104,
103, 102, 101, 5, 100 copies/μL) that was used to
determine standard curves and estimate gametocyte
densities reported as transcript copies/μL. All assays
were run in 384-well plate format on the Roche
LightCycler480® platform.
Data analysis
Data were compared between LM vs MF, LM vs RTPCR
and MF vs RTPCR for the number of sample pairs avail-
able in each of these three groups. Proportions were
compared by McNemar’s exact test. Sensitivity and spe-
cificity were calculated from the numbers of true/false
positives and negatives when each of the methods was
considered to be the reference method. Quantification of
gametocytes by each method was compared using cor-
relation analyses (Pearson), censored regression analyses
(Tobit regression [25]) and Bland-Altman analyses. Since
Table 1 Comparison of sensitivity and specificity of
gametocyte detection between light microscopy (LM),
magnetic fractionation (MF) and reverse transcriptase
polymerase chain reaction (RTPCR)
A1 LM Total A2 Reference
0 1 LM MF
MF 0 266 1 267 Sensitivity 0.99 0.39
1 136 88 224 Specificity 0.66 0.99
Total 402 89 491
B1 LM Total B2 Reference
0 1 LM RTPCR
RTPCR 0 110 3 113 Sensitivity 0.94 0.40
1 75 50 125 Specificity 0.59 0.97
Total 185 53 238
C1 RTPCR Total C2 Reference
0 1 RTPCR MF
MF 0 89 34 123 Sensitivity 0.74 0.77
1 29 99 128 Specificity 0.75 0.72
Total 118 133 251
In each of the three comparisons (A: LM vs MF; B: LM vs RTPCR and C: RTPCR
vs MF) both methods served as reference standard.
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ities/transcript copy numbers were normally distributed
(confirmed by Kolmogorov-Smirnov tests), these transfor-
mations were used in the analyses.
Results
Observed gametocyte positivity
Paired observations (LM vs MF) were available for 491
blood samples (402 originating from P. falciparum-infected
children and 89 from P. vivax-infected children). From the
subset of samples subjected to RTPCR, 238 paired obser-
vations for LM vs RTPCR (195 from P. falciparum- and 43
from P. vivax-infected children) and 251 paired observa-
tions for MF vs RTPCR (204 from P. falciparum- and 47
from P. vivax-infected children) were available. Since P.
vivax gametocytes are cleared rapidly after treatment, the
number of P. vivax-positive paired observations were very
limited in the present study.
Figure 1 shows the proportions of gametocyte-positive
observations for the three methods. Overall, LM resulted
in approximately 20% gametocyte-positive observations,
whereas MF and RTPCR both resulted in more than two-
fold higher observed gametocyte positivity (LM vs MF:
18.1 vs 45.6%, p < 0.0001; LM vs RTPCR: 22.2 vs 52.5%,
p < 0.0001; MF vs RTPCR: 51.0 vs 53.0%, p = 0.61). As
most blood samples originated from children who had
already received anti-malarial treatment, the proportions
displayed in Figure 1 do not reflect the gametocyte positiv-
ity rate in the population but should be viewed as a meas-
ure of how well the three methods were able to detect
gametocytes. At time of enrolment (prior to treatment)
observed gametocyte prevalence using LM was around
29% (20/70), whereas with both MF and RTPCR an ap-
proximate gametocyte positivity of 86% (60/70 for MF and
RTPCR) was found.
The comparative sensitivity and specificity of each of
the three gametocyte-detection methods are presented
in Table 1. Within each comparison, each method wasFigure 1 Proportion of gametocyte positive observations using LM vs
The analysis is purely concerned with the performance of the three metho
time the sample was taken. (n.s.: not significant; ***p-value <0.001 (McNemconsidered as the reference method (e.g., LM is com-
pared to MF once with LM as reference method and
once with MF as reference method). This is necessary
since LM is still considered the ‘gold standard’, yet its
sensitivity for gametocyte detection is inferior to both
MF and RTPCR methods, and analyses of specificity are
not meaningful if LM is used as the only reference
method as the number of ‘false positives’ will be biased.
When LM is compared to MF with LM as the reference
method, sensitivity is very high (99%), indicating that MF
detects nearly all positive cases detected by LM. Specificity
however is low, since LM is inferior to MF in sensitivity to
detect gametocytes and the analysis thus results in a high
number of ‘false positive’ observations. When MF is used
as the reference method in this comparison LM has a very. MF. (Panel A), LM vs. RTPCR (Panel B) and MF vs. RTPCR (Panel C).
ds and does not take into account the drug used for treatment or
ar’s test).
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dicating that MF indeed identifies nearly all gametocyte
carriers as correctly as LM.
The situation is similar when LM is compared to
RTPCR. Again, with LM as the reference method, RTPCR
sensitivity is high (94%) and specificity is artificially low.
When RTPCR is considered the reference standard, LM
sensitivity is low (40%) whereas specificity is high (97%)
indicating that RTPCR identifies most gametocyte carriers
correctly.
When MF is compared to RTPCR, interchanging the
reference methods has little effect. This indicates that
both of these methods are similarly sensitive and specific
for gametocyte detection, although they only agree with
each other moderately well (~75%).
Observed gametocyte densities
LM reports gametocyte density based on gametocyte
counts relative to leukocyte counts; MF uses an internal
standard in the form of magnetic microspheres [17];
RTPCR derives Pfs25 or Pvs25 copy numbers from a
standard curve. Figure 2 shows the gametocyte abun-
dance observed with the three methods (LM, RTPCR
and MF). The correlations between these measures are
highly significant (Pearson p < 0.0001). LM gametocyte
density estimates ranged from 16 and 9200 μL−1 for P.
falciparum and between 16 and 780 μL−1 for P. vivax.
When comparing the more sensitive methods (MF and
RTPCR) with LM, the data are heavily left-censored and
clustered on the LM limit of detection (LOD) which is
estimated to be 16 μL−1. Therefore, a censored linear re-
gression model (Tobit model) was chosen for regression
between LM and MF, and LM and RTPCR. The coeffi-
cients of determination (R2) from the Tobit regression
were 0.55 and 0.35 for LM vs MF and LM vs RTPCR, re-
spectively, implying only moderate degrees of predict-
ability. For comparison of MF and RTPCR, which are
both similarly sensitive, orthogonal linear regression was
used and R2 was 0.52.
MF gametocyte density estimates were also used to de-
rive a calibration curve between Pfs25/Pvs25 transcript
copy number and gametocyte number (Figure 2C). The
resulting equation to estimate gametocyte density (y)
from transcript copy number (x) was log10y = 0.97log10x-
1.51. In the epidemiologically relevant range (i.e., > 0.1
gametocytes per μL) of blood this corresponds to around
30–40 transcripts per gametocyte. This estimate of tran-
scripts per gametocyte is lower than the one previously
derived from serially diluted gametocyte cultures (~70-
110 transcripts per gametocyte) [21].
Since LM and MF both determine a gametocyte dens-
ity (LM based on a leukocyte count and MF based on a
count of gametocytes vs magnetic particles), the Bland
and Altman method comparison was used to comparethese two methods (Figure 2, Panel A) for those data
pairs that were not left-censored. [26] Bland and Altman
analysis showed no significant trends in the observed
differences between LM and MF over average gameto-
cyte density (Additional file 1), however it revealed that
the logarithms of the MF-based measures of gametocyte
density were biased consistently with a mean of −0.59
against the LM estimates. Therefore, to transform MF
gametocyte density into LM gametocyte density, this
bias was taken into account by adding 0.59 to each loga-
rithmic MF gametocyte density. The resulting corrected
95% confidence levels of agreement between LM and
MF were +/−0.93, meaning that MF and LM estimates
of gametocyte density can be expected to vary not more
than approximately ± ten-fold in 95% of measurements
(Figure 3).
Discussion
The aim of the present study was to assess the perform-
ance of MF compared to that of standard LM and RTPCR
for Pfs25 and Pvs25 for gametocyte detection in a field
study. Based on previous research, it was hypothesized
that MF would generate highly sensitive quantitative gam-
etocyte measurements under field conditions. MF showed
an at least similar ability to detect gametocyte carriers as
the RTPCR method, and both MF and RTPCR detected
significantly more gametocyte-positive samples than LM.
Measures of gametocyte density were strongly associated
between methods and conversions between them could be
derived. However, these conversions are associated with
considerable levels of uncertainty.
The results presented here show that MF was similarly
sensitive in detecting gametocytes as RTPCR conducted
on blood samples directly placed into an RNA preserva-
tion solution at the time of collection. While both MF and
RTPCR detected many (at least two to three-fold) more
gametocyte-positive samples than standard LM, there was
no significant difference in the proportions of gametocyte-
positive samples detected by MF and RTPCR (Figure 1)
indicating equivalent performance. Both MF and RTPCR
showed very high sensitivity (99 and 94%, respectively)
and specificity (99 and 97%, respectively) for gametocyte
detection when compared with LM. When compared to
RTPCR, MF showed similar sensitivity and specificity.
In terms of quantification, MF produced results that
were in agreement with LM observations (Figure 2A).
However, directly calculated gametocyte densities based
on the number of gametocytes per magnetic particle
were consistently lower than the gametocyte density es-
timates by LM. Since this phenomenon was systematic
across the entire range of observed gametocyte densities
(Figure S1), a simple correction for this negative bias
could be applied resulting in a good agreement between
LM gametocyte densities and the corrected MF derived
Figure 2 Relationship between gametocyte abundance measured
by LM, MF and RTPCR. Panel A: LM gametocyte density is plotted vs
MF gametocyte density. The data are heavily left-censored since many
observations cluster at the detection limit of LM. Therefore, a censored
regression (Tobit model [25]) was used instead of standard linear
regression, resulting in the depicted regression line. Panel B: LM
gametocyte density is plotted vs Pfs25 and Pvs25 copy numbers. The
black line is the best fit curve given by the Tobit regression. Panel C:
MF gametocyte density is plotted over RTPCR transcript copy number.
The continuous black line is the best fit by orthogonal regression. The
dashed black line is the reference estimate from serially diluted strain
3D7 gametocyte cultures published by Wampfler et al. [21].
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tions for this observed bias. Firstly, it has been shown that
the assumption of 8,000 WBCs per μL of blood may lead
to an overestimate of parasite density (if individuals
have lower WBC counts) [27]. However, automated WBC
counts from children in the present study did not indicate
large deviation from the assumed 8,000 WBC per μL [28].
Another possible explanation is the differential magnetic
susceptibility between magnetic particles and gametocytes.
The magnetic particles used in the present study had a
significantly higher magnetic susceptibility compared to
gametocytes which may lead to a differential capture effi-
ciency of magnetic particles and gametocytes in the MF
columns. Previous studies have shown that the capture ef-
ficiency for gametocytes by MF is approximately 50% [29].
This may lead to a consistent underestimation of gameto-
cyte density by MF. The usage of magnetic particles that
have the same magnetic susceptibility as gametocytes may
reduce this effect.
MF estimates of gametocyte densities were used to de-
rive a log-linear equation to convert transcript copy num-
ber of Pfs25 or Pvs25 into gametocyte densities. The
resulting estimates for the number of transcripts per gam-
etocyte are lower than that in previous studies (less tran-
scripts per gametocyte, Figure 2C), which may be due to
several reasons: i) although the ratio of blood to RNA pres-
ervation reagent and ultimately, the blood volume sub-
jected to the RTPCR reaction, was very similar to that used
in the study by Wampfler et al. [21], even slight differences
in the extraction and amplification protocols may result in
considerable differences in the observed transcript copy
numbers; ii) although the samples were placed in RNA
preservation reagent, several hours could pass before these
samples were transferred from the field to the laboratory
and for frozen storage and this may have led to some RNA
degradation [30]; and, iii) while Wampfler et al. [21] de-
rived the standard curve using serially diluted
laboratory-cultured gametocytes that were synchronous
stage V, the estimate in the present study is based on
much more variable data (field based gametocyte counts
including all identifiable gametocyte maturation stages)
Figure 3 Corrected Bland and Altman comparison between LM
and MF. The 95% confidence levels of agreement were +/−0.93
(dotted lines in the graph).
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gametocyte is expectable.
The present study shows that MF can be a valuable tool
in determining gametocyte positivity and density under
field conditions in malaria studies. Although MF is slower
when conducted on batches of samples, it has the advan-
tage over RTPCR that it can be directly applied in the field
without much additional equipment or expertise and with-
out concerns regarding contamination or appropriate sam-
ple storage. Direct identification of gametocyte carriers, is
important if targeted primaquine treatment of P. falcip-
arum gametocyte carriers is considered to reduce trans-
mission of P. falciparum. In order to minimize the risk of
primaquine toxicity, MF could be used to confirm gameto-
cyte carriage even if the health centre is remote and with
limited electricity [5,31,32]. Furthermore, since symptom-
atic vivax malaria is less frequent in countries such as
PNG, MF can be used to improve recruitment rates of
eligible patients with gametocytes into epidemiological
follow-up studies or primaquine dose escalating trials aim-
ing to identify optimal dosing schedules.
The present study provides evidence that MF is a feas-
ible methodology for field-based gametocyte detection
that can be applied even in larger scale studies. With an
appropriate set-up, four to six samples could conveni-
ently be processed by one person in an hour with results
being available for all samples after approximately 1.5 hr.Conclusions
The present study shows that magnetic fractionation is a
very good alternative method for on-site gametocyte detec-
tion under field conditions. The method has, as previously
shown under laboratory conditions, similar sensitivity to
RTPCR and can be used to derive quantitative gametocyte
densities for both P. falciparum and P. vivax.Additional file
Additional file 1: Bland and Altman comparison between LM and
MF. A consistent negative bias of −0.59 between MF and LM was
observed and corrected for (shown in Figure 3 in the main text).
The red horizontal line denotes ‘0 bias’.
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